Anticancer Daclatasvir Pharmaceutical Grade Daclatasvir Powder Raw Powder Daclatasvir
China Anticancer Daclatasvir Pharmaceutical Grade Daclatasvir Powder Raw Powder Daclatasvir, Find details about China Daclatasvir, Anticancer Daclatasvir from Anticancer Daclatasvir Pharmaceutical Grade Daclatasvir Powder Raw Powder Daclatasvir
Basic Info.
Model NO.
Condavo-Daclatasvir
Name
Daclatasvir
Product Name
Daclatasvir Powder
Appearance
White Powder
Color
White Color
Test Method
HPLC UV
Storage
Cool Dry Place
Shelf Life
2 Years
Assay
99%
Grade
Pharmaceutical Grade
COA
Available
Mf
C40h50n8o6
Shining Point
601.664 C
Density
1.25 g/cm3
Molecular Weight
738.875
CAS
1009119-64-5
Trademark
Condavo
Transport Package
1kg/ Aluminium Bag or 25kg/Drum; as Required
Specification
99%
Origin
Shaanxi
Model NO.
Condavo-Daclatasvir
Name
Daclatasvir
Product Name
Daclatasvir Powder
Appearance
White Powder
Color
White Color
Test Method
HPLC UV
Storage
Cool Dry Place
Shelf Life
2 Years
Assay
99%
Grade
Pharmaceutical Grade
COA
Available
Mf
C40h50n8o6
Shining Point
601.664 C
Density
1.25 g/cm3
Molecular Weight
738.875
CAS
1009119-64-5
Trademark
Condavo
Transport Package
1kg/ Aluminium Bag or 25kg/Drum; as Required
Specification
99%
Origin
Shaanxi
Product Desciption
Anticancer Daclatasvir Pharmaceutical Grade Daclatasvir Powder Raw Powder Daclatasvir
Daclatasvir is a medication used in combination with other medications to treat hepatitis C (HCV). The other medications used in combination include sofosbuvir, ribavirin, and interferon, vary depending on the virus type and whether the person has cirrhosis.
| Product Name | Daclatasvir |
| Appearance | White Powder |
| MF | C40h52cl2n8o6 |
| CAS | 1009119-64-5 |
| Shelf Life | 2 Years |
Daclatasvir is a direct-acting antiviral agent against Hepatitis C Virus (HCV) used for the treatment of chronic HCV genotype 1 and 3 infection.Hepatitis C is an infectious liver disease caused by infection with Hepatitis C Virus (HCV). Daclatasvir was discovered as a first-in-class inhibitor of the non-structural viral protein 5A (NS5A), a phosphoprotein that plays an important role in hepatitis C replication.
Common side effects with sofusbivir and daclatasvir include headache, feeling tired, and nausea. With daclatasvir, sofusbivir, and ribavirin the most common side effects are headache, feeling tired, nausea, and red blood cell breakdown.
Daclatasvir is first without joint interferon can be safe and effective drug for the treatment of certain types of hepatitis c.Clinical trials confirm for type 1 and 4 c, the drug combination of polyethylene glycol (peg) interferon and ribavirin overall sustained virological response (SVR) is as high as 90%;In view of the type 2 c, the drug plus ribavirin SVR is 89% - 95%;In view of the 3 c, the drug plus ribavirin SVR is 61% - 63%.
You Might Also Like
Plastic Paving Concrete Mold DIY Walkway Stones Mould Landsc......
Baroque Freshwater Pearl Necklace fashion Jewelry Jewellery ......
China Professional Made Super Big Size Ductile Iron Flange P......
Supermarket Storage Container Plastic Folding Stackable Coll......
Plastic Disposable Hitachi Beckman Sample Cup
Bulk Pen Drive Wood USB Flash Drive
Debo 5 Years Warranty HPL Toilet Cubicle Board
Luxury Hotel 1500 Supreme Collection Bed Sheet Set
Sodium Hyaluronic Acid Gel Injection for Lip, Face, Nose, Br......
Fenugreek Seed Extract 4-Hydroxyisoleucine for Improve Insul......
Rechargeable Battery 25ah 3.2V LiFePO4 Battery Cell
Radial Truck Tyre 10.00r20 11.00r20 12.00r20, TBR